SJM
14
3
NEE
52
2
NWL
57
3
OKE
64
-3
LNC
70
-2
MDLZ
28
4
F
58
2
PHM
43
2
GT
39
2
SWKS
56
8
MU
79
3
ETR
52
3
AZO
46
-2
MMC
60
3
UPS
40
2
COP
44
-3
HSIC
62
-3
COST
53
5
LH
48
2
EXC
53
3
SJM
14
3
NEE
52
2
NWL
57
3
OKE
64
-3
LNC
70
-2
MDLZ
28
4
F
58
2
PHM
43
2
GT
39
2
SWKS
56
8
MU
79
3
ETR
52
3
AZO
46
-2
MMC
60
3
UPS
40
2
COP
44
-3
HSIC
62
-3
COST
53
5
LH
48
2
EXC
53
3
Financhill
Back

Intellia Therapeutics, Inc. Vs. Triumph Financial, Inc. Industry Stock Comparison

Sell
22

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.59
Seasonality Move:
-4.79%
Buy
68

TFIN
Triumph Financial, Inc.

Last Price:
$64.24
Seasonality Move:
2.9%
Sell
22
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.59. The Score for NTLA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Triumph Financial, Inc. (TFIN) is a Buy

Is Triumph Financial, Inc. a Buy, Sell or Hold?

  • The current Triumph Financial, Inc. [TFIN] share price is $64.47. The Score for TFIN is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • TFIN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.59
    The current trend is relatively stagnant and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

TFIN Stock Price Chart

What is Triumph Financial, Inc.'s stock price today?

  • The Triumph Financial, Inc. share price today is $64.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 47.26 Sell
Chaikin Money Flow: 1208875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.45 - 9.51) Buy
Bollinger Bands (100): (7.99 - 18.91) Sell

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.86 Buy
Relative Strength Index (14 RSI): 64.11 Buy
Chaikin Money Flow: 83857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.82 - 63.52) Buy
Bollinger Bands (100): (51.32 - 60.98) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.23 Buy
20-day SMA: 9.15 Buy
50-day SMA: 12.44 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.34 Buy
20-day EMA: 9.48 Buy
50-day EMA: 11.2 Sell
200-day EMA: 12.77 Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.51 Buy
20-day SMA: 60.76 Buy
50-day SMA: 57.01 Buy
200-day SMA: 57.06 Buy
8-day EMA: 49.87 Buy
20-day EMA: 28.87 Buy
50-day EMA: 13.64 Buy
200-day EMA: 3.72 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Triumph Financial, Inc. Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $1.18 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):